News

Fort Lauderdale, FL-Latanoprost, bimatoprost, and travoprost have comparable IOP-lowering effectiveness in patients with open-angle glaucoma or ocular hypertension, according to a recent study.

Orlando-Adjustment for energy delivery calibration errors represents the single most important step excimer laser manufacturers can take toward achieving improved visual outcomes in eyes undergoing corneal ablative refractive surgery, said Jack T. Holladay, MD, MSEE, FACS, at the annual meeting of the American College of Surgeons.

If ophthalmologists and other physicians are looking to the nation's capital for assistance in dealing with the jury awards that far exceed actual economic losses by plaintiffs, one doctor believes it is a colossal waste of time.

Dallas-Moxifloxacin ophthalmic solution (Vigamox 0.5%, Alcon Laboratories) was approved by the FDA on April 16 for the treatment of bacterial conjunctivitis, following a 6-month review of the drug.

San Francisco-LASIK is a safe, effective, and accurate treatment for correcting ametropia in post-radial keratotomy (RK) eyes, reported Stephen M. Weinstock, MD, at the annual meeting ofthe American Society of Cataract and Refractive Surgery here.

Newark, NJ-Topical beta-blockers are much safer than physicians believe them to be, according to New Jersey glaucoma specialist Paul Lama, MD.

San Francisco-With the presbyopic population reaching 51% (141 million) in the United States, the interest in surgical correction of presbyopia will likely take off as the baby boomers look for alternatives to glasses, according to Richard L. Lindstrom, MD, who delivered the Binkhorst Lecture during the opening session of the American Society of Cataract and Refractive Surgery annual meeting.

Fort Lauderdale, FL-An increase in outflow facility appears to be the mechanism by which unoprostone isopropyl ophthalmic solution (Rescula 0.15%, Novartis) reduces IOP, said Carol B. Toris, PhD.

San Francisco-Nearly 100,000 people in the United States are blind from glaucoma, and this number will rise enormously as the population ages over the next 20 years unless better detection and treatment methods are developed, said Nathan G. Congdon, MD, MPH.

Editor's Note: Anterior uveitis is the most common type of intraocular inflammation. Among patients with inflammation localized primarily to the anterior chamber, 50% or more are HLA-B27 positive. Inaddition, a number of these patients with HLA-B27-associated anterior uveitis have, or will develop, an associated systemicdisorder such as ankylosing spondylitis,reactive arthritis (formerly known asReiter's syndrome), inflammatory bowel disease, or psoriatic arthritis.

Johannesburg, South Africa-A miniature glau-coma implant (Ex-Press, Optonol Ltd., Neve Ilan, Israel; marketed by CIBA Vision, Atlanta) that is implanted under a scleral flap has been shown to be safe and effective in lowering IOP in a prospective pilot study.

Del Mar, CA-Eyemakers Inc. has signed a letter of intent to acquire a public company that provides LASIK surgery to patients in the Southwest.

Cleveland-A protein produced by the body might help prevent abnormal blood vessel growth and treat diseases such as wet age-related macular degeneration, diabetic retinopathy, and cancer.

Washington, DC-The Centers for Medicare and Medicaid Services (CMS) has expanded the list of procedures it will cover, including several important ophthalmic procedures.

The FDA is looking for more analysis of data before deciding whether to approve ISTA Pharmaceuticals' ovine hyaluronidase compound for the treatment of vitreous hemorrhage.

Orlando-The key to success in today's competitive contact lens market is to offer complete service and a full array of specialty contact lenses, according to one expert.

Woburn, MA-Advanced Vision Research has joined the growing number of physicians who have concluded that the anti-inflammatory properties of omega-3 fatty acids, such as those found in flaxseed oil, can relieve dry eye. The company recently added a dietary supplement containing these acids, TheraTears Nutrition, to its line of dry eye products.

Baltimore-LASIK presents a challenge to normal tear film dynamics, and some patients may be affected by prolonged neurotrophic epitheliopathy.

The paradigm of dry eye treatment is the use of solutions and lubricants applied to the eye. That is, dry eyes require topical medication in the form of artificial tears to restore tear production and comfort. Anything other than this is contrary to belief and intuition and a paradigm shift.

Los Angeles-Insertion of the Herrick Lacrimal Plug (HLP, Lacrimedics, Eastsound, WA) appears to be trouble-free for the majority of patients, with significant complications wuch as pyogenic granuloma and probing occurring in less than 10% of cases, said John C. Affeldt, MD, MPH.

Jacksonville, FL-In any disease, the differential diagnosis is paramount to ensure proper treatment. This is also true for patients who complain of dry eye before and after LASIK. Arun C. Gulani, MD, created a decision pyramid that allows him to get to the root of complaints of dry in his patients.

San Francisco-At 1-year follow-up, the majority of patients who received the hyperopic Implantable Contact Lens (ICL, STAAR Surgical, Monrovia, CA) for correction of moderate to high hyperopia were satisfied with an uncorrected visual acuity (UCVA) of at least 20/40 or better, noted Paul J. Dougherty, MD, who spoke during the American Society of Cataract and Refractive Surgery Annual Meeting.

Montreal-In the clinical setting, night vision disturbances after LASIK cannot be predicted by pupil size, but rather are correlated with preoperative sphere and the photoablation optical zone size, said Mihai Pop, MD.

Columbus, OH-Age-adjusted approaches are needed for the evaluation and management of suspected orbital fracture in pediatric patients because children are different from adults, according to JDespite the introduction of more accurate IOL formulas and biometry instrumentation, cataract and refractive lens surgery have yet to achieve the ophthalmologist's ideal of perfect emmetropia in all cases.1-5 This limitation stems from occasional inaccuracies in keratometry and axial length measurements, an inability to assess the final position of the pseudophakic implant accurately in a fibrosing capsular bag, and the difficulty of completely eliminating pre-existing astigmatism despite the use of limbal relaxing incisions and toric IOLs.6,7 A new lens technology offers the hope of taking ophthalmologists one step closer to achieving emmetropia in all cases and also perhaps further improving the final result by addressing higher-order optical aberrations.

Columbus, OH-Age-adjusted approaches are needed for the evaluation and management of suspected orbital fracture in pediatric patients because children are different from adults, according to Jill A. Foster, MD.

San Francisco-Confocal microscopy is an excellent supplement to the slit-lamp examination for identifying suspected pathology by viewing specific layers of the anterior segment, according to Herbert E. Kaufman, MD, who spoke during the Innovator's Session at the American Society of Cataract and Refractive Surgery Annual Meeting.

Salt Lake City-Patients with pseudoexfoliation who have undergone cataract surgery are at risk for spontaneous IOL dislocation years after the procedure, according to Alan S. Crandall, MD.

Special keynote speech to be delivered by Dr. Folkman of Harvard MedicalSchoolThe Association for Research in Vision and Ophthalmology (ARVO) turns75 years this year. To commemorate this major milestone, several specialevents are planned during the annual meeting from May 4 to 8 in Fort Lauderdale,FL.The anniversary celebration will officially open with a keynote symposiumon Sunday, May 4 at 5 p.m. during which Judah Folkman, MD, director of surgicalresearch, and the Andrus professor of pediatric surgery and professor ofcell biology, Children's Hospital, Harvard Medical School, Boston, willdeliver the keynote address. The 75th Anniversary Celebration Social willfollow from 7 to 9 p.m.

CA-The FDA approval of gatifloxacin ophthalmic solution 0.3% (Zymar, Allergan) marks a milestone as the first fourth-generation fluoroquinolone to enter the ophthalmic market. The therapy for the treatment of bacterial conjunctivitis caused by susceptible strains of bacteria also has a unique mechanism to prevent development of antibiotic resistance, according to Allergan.

Taking outdoor activities to an extreme is a way of life for William L. Benedict, MD. Whether it's kayaking, mountain biking, or snow skiing, he is constantly pushing his skills to the limit.